STOCK TITAN

OSR Health Inc Financials

OSRH
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows OSR Health Inc (OSRH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OSRH FY2025

Recapitalized balance sheet but cash-hungry operations leave a large asset base supported by only $2.9M of revenue.

FY2025 flipped equity from -$8.3M to $127.0M, a dramatic repair in long-term balance-sheet posture. But the current ratio fell to 0.2x, so solvency improved faster than liquidity; the company looks less burdened by liabilities overall while still tight on near-term cash needs.

Revenue scale is still too small for the overhead base: $2.9M of FY2025 sales produced only $593K of gross profit. That gap implies the operating loss is being driven more by corporate costs above gross profit than by product-level economics alone, even before considering interest or other below-the-line items.

Cash conversion remained weak: -$4.3M of operating cash outflow was covered by $8.4M of financing inflow. That means the business still depended on outside capital to fund itself, and the much larger share count shows that support did not come from internally generated cash or a naturally cash-producing operating cycle.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 22 / 100
Financial Health Score 22/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of OSR Health Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
22

OSR Health Inc has an operating margin of -631.0%, meaning the company retains $-631 of operating profit per $100 of revenue. This below-average margin results in a low score of 22/100, suggesting thin profitability after operating expenses. This is down from -331.2% the prior year.

Growth
6

OSR Health Inc's revenue declined 17.7% year-over-year, from $3.5M to $2.9M. This contraction results in a growth score of 6/100.

Leverage
66

OSR Health Inc carries a low D/E ratio of 0.35, meaning only $0.35 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 66/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
1

OSR Health Inc's current ratio of 0.16 is below the typical benchmark, resulting in a score of 1/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Returns
36

OSR Health Inc's ROE of -21.3% shows moderate profitability relative to equity, earning a score of 36/100.

Altman Z-Score Distress
-0.52

OSR Health Inc scores -0.52, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($16.0M) relative to total liabilities ($44.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
1/8

OSR Health Inc passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality
0.16x

For every $1 of reported earnings, OSR Health Inc generates $0.16 in operating cash flow (-$4.3M OCF vs -$27.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-36.2x

OSR Health Inc earns $-36.2 in operating income for every $1 of interest expense (-$18.3M vs $506K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.9M
YoY-17.7%

OSR Health Inc generated $2.9M in revenue in fiscal year 2025. This represents a decrease of 17.7% from the prior year.

EBITDA
-$9.0M
YoY-339.3%

OSR Health Inc's EBITDA was -$9.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 339.3% from the prior year.

Net Income
-$27.1M
YoY-1022.4%

OSR Health Inc reported -$27.1M in net income in fiscal year 2025. This represents a decrease of 1022.4% from the prior year.

EPS (Diluted)
$-0.80

OSR Health Inc earned $-0.80 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$1.7M
YoY+397.8%

OSR Health Inc held $1.7M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
27M

OSR Health Inc had 27M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
20.4%
YoY-2.6pp

OSR Health Inc's gross margin was 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.6 percentage points from the prior year.

Operating Margin
-631.0%
YoY-299.8pp

OSR Health Inc's operating margin was -631.0% in fiscal year 2025, reflecting core business profitability. This is down 299.8 percentage points from the prior year.

Net Margin
-931.2%
YoY-862.9pp

OSR Health Inc's net profit margin was -931.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 862.9 percentage points from the prior year.

Return on Equity
-21.3%

OSR Health Inc's ROE was -21.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
$318K
YoY+97.6%

OSR Health Inc invested $318K in research and development in fiscal year 2025. This represents an increase of 97.6% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

OSRH Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $484K+27.0% $381K-39.3% $628K-44.7% $1.1M+49.2% $761K-16.8% $915K+11.2% $823K-6.7% $882K
Cost of Revenue $324K+28.7% $252K-31.3% $366K-66.8% $1.1M+86.1% $593K-21.5% $755K+17.3% $644K-0.9% $650K
Gross Profit $160K+23.6% $130K-50.4% $262K+698.4% $33K-80.6% $169K+5.4% $160K-10.6% $179K-22.9% $232K
R&D Expenses $113K N/A N/A N/A $90K N/A N/A N/A
SG&A Expenses $3.8M-41.3% $6.5M+60.3% $4.1M-22.7% $5.3M+70.5% $3.1M+74.1% $1.8M-52.7% $3.7M+8.8% $3.4M
Operating Income -$3.7M+42.6% -$6.4M-67.9% -$3.8M+27.3% -$5.2M-79.2% -$2.9M-80.9% -$1.6M+54.8% -$3.6M-11.1% -$3.2M
Interest Expense $31K-92.4% $409K+832.4% $44K+18.8% $37K+125.2% $16K-59.1% $40K+339.8% $9K+340.3% $2K
Income Tax -$452K N/A -$1.3M N/A N/A -$451K-222.9% -$140K+85.7% -$974K
Net Income -$3.5M+52.1% -$7.2M-126.8% -$3.2M+38.9% -$5.2M+54.1% -$11.4M-463.4% -$2.0M-775.6% -$231K-137.4% -$97K
EPS (Diluted) $-0.08 N/A N/A N/A $-1.04 N/A $-0.06-200.0% $-0.02

OSRH Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $172.2M+0.6% $171.2M-3.4% $177.3M-4.4% $185.4M+6.2% $174.6M-0.4% $175.2M+737.4% $20.9M+1.4% $20.6M
Current Assets $2.9M+3.8% $2.8M-12.1% $3.2M+11.4% $2.9M-17.1% $3.5M+49.0% $2.3M+5773.8% $40K-76.3% $167K
Cash & Equivalents $1.6M-7.9% $1.7M-21.9% $2.2M+37.4% $1.6M-0.7% $1.6M+367.2% $342K+2691.3% $12K-89.7% $119K
Inventory $462K+135.4% $196K+6.1% $185K-6.9% $199K-73.0% $737K-20.1% $922K N/A N/A
Accounts Receivable $261K-18.1% $319K-34.7% $489K-34.1% $743K-6.5% $795K-12.2% $904K N/A N/A
Goodwill $29.7M+19.2% $24.9M-2.3% $25.5M-3.3% $26.4M+8.1% $24.4M+0.2% $24.4M N/A N/A
Total Liabilities $44.8M+1.3% $44.2M+2.5% $43.1M-6.8% $46.3M+9.4% $42.3M-77.0% $183.6M+588.1% $26.7M+4.5% $25.5M
Current Liabilities $17.9M+4.3% $17.2M+14.2% $15.0M-5.2% $15.9M+14.2% $13.9M+300.9% $3.5M-12.1% $3.9M+15.3% $3.4M
Long-Term Debt $273K N/A $0 N/A $253K-49.1% $498K N/A N/A
Total Equity $127.4M+0.3% $127.0M-5.3% $134.2M-3.6% $139.2M+5.2% $132.3M+1687.4% -$8.3M-44.8% -$5.8M-17.3% -$4.9M
Retained Earnings -$40.1M-7.9% -$37.2M-15.0% -$32.3M-7.1% -$30.2M+1.3% -$30.6M-59.4% -$19.2M-233.2% -$5.8M-17.3% -$4.9M

OSRH Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$1.0M+6.4% -$1.1M+60.5% -$2.7M-461.8% -$483K-653.3% -$64K+64.6% -$181K+73.6% -$686K-42.1% -$483K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $12K+100.5% -$2.6M-254.2% -$727K-37.5% -$528K-144.6% $1.2M+731.3% -$188K-176.6% $245K+11.7% $220K
Financing Cash Flow $942K-70.7% $3.2M-22.0% $4.1M+361.7% $891K+496.8% $149K-53.5% $322K-4.9% $338K+30.9% $258K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A $19.2M $0 N/A

OSRH Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 33.1%-0.9pp 34.0%-7.7pp 41.7%+38.8pp 2.9%-19.3pp 22.2%+4.7pp 17.5%-4.3pp 21.8%-4.6pp 26.4%
Operating Margin -757.6%+917.2pp -1674.8%-1068.9pp -605.9%-145.4pp -460.5%-77.2pp -383.3%-207.0pp -176.2%+257.1pp -433.4%-69.3pp -364.0%
Net Margin -716.3%+1184.1pp -1900.4%-1391.5pp -508.9%-48.8pp -460.2%+1036.4pp -1496.5%-1275.6pp -220.9%-192.9pp -28.1%-17.0pp -11.0%
Return on Equity -2.7%+3.0pp -5.7%-3.3pp -2.4%+1.4pp -3.8%+4.8pp -8.6% N/A N/A N/A
Return on Assets -2.0%+2.2pp -4.2%-2.4pp -1.8%+1.0pp -2.8%+3.7pp -6.5%-5.4pp -1.1%-0.1pp -1.1%-0.6pp -0.5%
Current Ratio 0.160.0 0.16-0.0 0.21+0.0 0.18-0.1 0.25-0.4 0.67+0.7 0.01-0.0 0.05
Debt-to-Equity 0.00-0.3 0.35+0.3 0.00-0.3 0.33+0.3 0.00 N/A N/A N/A
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: The current ratio is below 1.0 (0.16), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

OSR Health Inc (OSRH) reported $2.9M in total revenue for fiscal year 2025. This represents a -17.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

OSR Health Inc (OSRH) revenue declined by 17.7% year-over-year, from $3.5M to $2.9M in fiscal year 2025.

No, OSR Health Inc (OSRH) reported a net income of -$27.1M in fiscal year 2025, with a net profit margin of -931.2%.

OSR Health Inc (OSRH) reported diluted earnings per share of $-0.80 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

OSR Health Inc (OSRH) had EBITDA of -$9.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

OSR Health Inc (OSRH) had a gross margin of 20.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

OSR Health Inc (OSRH) had an operating margin of -631.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

OSR Health Inc (OSRH) had a net profit margin of -931.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

OSR Health Inc (OSRH) has a return on equity of -21.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

OSR Health Inc (OSRH) generated -$4.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

OSR Health Inc (OSRH) had $171.2M in total assets as of fiscal year 2025, including both current and long-term assets.

OSR Health Inc (OSRH) invested $318K in research and development during fiscal year 2025.

OSR Health Inc (OSRH) had 27M shares outstanding as of fiscal year 2025.

OSR Health Inc (OSRH) had a current ratio of 0.16 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

OSR Health Inc (OSRH) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

OSR Health Inc (OSRH) had a return on assets of -15.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, OSR Health Inc (OSRH) had $1.7M in cash against an annual operating cash burn of $4.3M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

OSR Health Inc (OSRH) has an Altman Z-Score of -0.52, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

OSR Health Inc (OSRH) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

OSR Health Inc (OSRH) has an earnings quality ratio of 0.16x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

OSR Health Inc (OSRH) has an interest coverage ratio of -36.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

OSR Health Inc (OSRH) scores 22 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top